Logo image of AVNS

AVANOS MEDICAL INC (AVNS) Stock Analyst Ratings

NYSE:AVNS - New York Stock Exchange, Inc. - US05350V1061 - Common Stock - Currency: USD

15.52  +0.07 (+0.45%)

Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to AVNS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.4. This target is 31.44% above the current price.
AVNS was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about AVNS.
In the previous month the buy percentage consensus was at a similar level.
AVNS was analyzed by 7 analysts. More opinions would make the average more meaningful.
AVNS Historical Analyst RatingsAVNS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 15.5220.2020.4020.4021.00 - 30.15% 31.44% 31.44% 35.31%
AVNS Current Analyst RatingAVNS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-05-07 JMP Securities Reiterate Market Perform
2023-07-25 Keybanc Downgrade Overweight -> Sector Weight
2023-06-21 Stifel Reiterate Hold -> Hold
2023-05-22 CL King Initiate Buy
2023-05-04 Morgan Stanley Maintains Underweight
2023-02-22 Morgan Stanley Maintains Underweight
2023-01-06 Morgan Stanley Maintains Underweight
2022-11-03 Keybanc Maintains Overweight
2022-10-11 Morgan Stanley Maintains Underweight
2022-08-10 Keybanc Maintains Overweight
2022-07-18 Stifel Maintains Hold
2022-07-15 Morgan Stanley Maintains Underweight
2022-05-05 Morgan Stanley Maintains Underweight
2022-02-24 Keybanc Maintains Overweight
2022-01-07 Morgan Stanley Maintains Underweight
2021-08-04 Keybanc Maintains Overweight
2021-08-04 Stephens & Co. Downgrade Overweight -> Equal-Weight
2021-08-04 Morgan Stanley Maintains Underweight